Latest Data


« Join The Fight Against Cancer Radiation, Chemo Costs Drive Cancer Spending In U.s. (reuters) | Main | Current Initial Colonoscopy Key To Cancer Detection (healthday) »

Comments Requested Sound Pharmaceuticals Files Second Ind With The Fda For The Prevention Of Chemotherapy Induced Hearing Loss In Advanced Stage Cancer

By admin2 | October 4, 2008

MedicalSound Pharmaceuticals (SPI) has filed an Investigational New Drug Application with the FDA for the clinical testing of a proprietary formulation of ebselen for the prevention of chemotherapy induced hearing loss or ototoxicity. The oral capsule containing ebselen, SPI-3005, will be tested in advanced stage lung cancer and head and neck cancer patients receiving platinum based chemotherapy.
(Link)

This entry was important to me: These icons link to social bookmarking sites where readers can share and discover new web pages.
  • StumbleUpon
  • Digg
  • del.icio.us
  • Reddit
  • Furl
  • Junipo

Topics: Cancer |

Comments